SOMAXON PHARMACEUTICALS
Somaxon Pharmaceuticals is a growing specialty pharmaceutical company dedicated to commercializing proprietary branded prescription therapeutics to treat important medical conditions where there is an unmet medical need and/or high-level of patient dissatisfaction. The company currently is focusing on in-licensing, developing and marketing proprietary products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area. Somaxon currently is promoting Silenorยฎ, the first and only nonscheduled prescription medication approved for the treatment of sleep maintenance insomnia. Silenor is now available for prescription in the United States.
SOMAXON PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2003-01-01
Address:
Solana Beach, California, United States
Country:
United States
Website Url:
http://www.somaxon.com
Total Employee:
251+
Status:
Active
Contact:
858-876-6500
Email Addresses:
[email protected]
Total Funding:
94 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Domain Not Resolving Wordpress Plugins Nginx Euro
Similar Organizations
Pacira Pharmaceuticals
Pacira Pharmaceuticals is a specialty pharmaceutical company dedicated to postsurgical innovation.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical companyย focused on theย prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Prospect Venture Partners
Prospect Venture Partners investment in Post-IPO Equity - Somaxon Pharmaceuticals
MPM Capital
MPM Capital investment in Post-IPO Equity - Somaxon Pharmaceuticals
Domain Associates
Domain Associates investment in Post-IPO Equity - Somaxon Pharmaceuticals
Tavistock Life Sciences
Tavistock Life Sciences investment in Post-IPO Equity - Somaxon Pharmaceuticals
Scale Venture Partners
Scale Venture Partners investment in Post-IPO Equity - Somaxon Pharmaceuticals
Montreux Equity Partners
Montreux Equity Partners investment in Post-IPO Equity - Somaxon Pharmaceuticals
Prospect Venture Partners
Prospect Venture Partners investment in Series C - Somaxon Pharmaceuticals
MPM Capital
MPM Capital investment in Series C - Somaxon Pharmaceuticals
Domain Associates
Domain Associates investment in Series C - Somaxon Pharmaceuticals
CDIB BioScience Ventures
CDIB BioScience Ventures investment in Series C - Somaxon Pharmaceuticals
Official Site Inspections
http://www.somaxon.com
- Host name: 173-198-247-252.static.as40244.net
- IP address: 173.198.247.252
- Location: Latham United States
- Latitude: 42.747
- Longitude: -73.7527
- Metro Code: 532
- Timezone: America/New_York
- Postal: 12110